Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Reumoxicam vs Movalis
NCT05125588Phase 1Completed
- Sponsor
- Farmak
- Start
- Jan 2014
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of meloxicam in osteoarthritis (OA) and rheumatoid arthritis (RA) (2 arms), sponsored by Farmak. Primary endpoints: Area Under the Concentration-Time Curve From Time Zero to Last Quantifiable Concentration and Maximum Plasma Concentration. Started Jan 2014; status: completed.
02
Drugs
meloxicam
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05125588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05125588.